PTGS2 and neoplasm: Results showed that Mel + TMZ significantly suppressed tumour growth compared to monotherapy, and the degree of tumour inhibition was comparable to that of Celecoxib + TMZ, suggesting COX‐2 as a critical mediator of the combinatorial efficacy.